Current Portfolio

Flagship invests in three principle business sectors: Therapeutics; Health Technologies; and Sustainability. Initial investments range between $250 thousand and $5 million, and we may invest up to $12-15 million during the life of a company. Click on a tab below to filter the listing of the portfolio by industry sector, or on a column heading to sort.

Company Description Statussort icon Initial Date
<a href="/venture-capital/all-companies/agios-pharmaceuticals-inc">Agios Pharmaceuticals, Inc.</a> Discovering and developing novel drugs to treat cancer and inborn errors of metabolism. Public 2007 View Profile
<a href="/venture-capital/all-companies/t2-biosystems-inc">T2 Biosystems, Inc.</a> Developing innovative diagnostic products to improve patient health. Public 2006 View Profile
<a href="/venture-capital/all-companies/seres-therapeutics">Seres Therapeutics</a> Developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome. Public 2012 View Profile
<a href="/venture-capital/all-companies/editas-medicine">Editas Medicine</a> Leading genome editing company translating its proprietary technology into novel solutions to treat a broad range of genetically-driven diseases. Public 2013 View Profile
<a href="/venture-capital/all-companies/joule-unlimited-inc">Joule Unlimited, Inc.</a> Pioneering a CO2-to-fuel production platform, effectively reversing combustion through the use of solar energy. Private 2007 View Profile
<a href="/venture-capital/all-companies/selecta-biosciences-inc">Selecta Biosciences, Inc.</a> Developing novel drugs that use immune modulating nanomedicines to generate targeted antigen-specific immune responses to prevent and treat disease. Private 2008 View Profile
<a href="/venture-capital/all-companies/seventh-sense-biosystems-inc">Seventh Sense Biosystems, Inc.</a> Developing an array of products based on the company's proprietary TAP™ (Touch Activated Phlebotomy) painless blood collection platform. Private 2007 View Profile
<a href="/venture-capital/all-companies/transmedics-inc">TransMedics, Inc.</a> Extending the life saving benefits of organ transplantation to patients suffering from end-stage organ failure. Private 2010 View Profile
<a href="/venture-capital/all-companies/black-duck-software-inc">Black Duck Software, Inc.</a> Providing the world’s only end-to-end platform for OSS Logistics. Private 2004 View Profile
<a href="/venture-capital/all-companies/incredible-foods">Incredible Foods</a> Commercializing breakthrough, innovative products in human nutrition. Private 2012 View Profile
<a href="/venture-capital/all-companies/taris-biomedical-inc">TARIS Biomedical, Inc.</a> Developing novel treatments for urologic diseases. Private 2008 View Profile
<a href="/venture-capital/all-companies/novomer-inc">Novomer, Inc.</a> Commercializing a family of low-cost, high-performance, sustainable polymers and other chemicals. Private 2007 View Profile
<a href="/venture-capital/all-companies/oasys-water-inc">Oasys Water, Inc.</a> Developing innovative solutions for water treatment and desalination in industrial markets around the globe. Private 2009 View Profile
<a href="/venture-capital/all-companies/visterra-inc">Visterra, Inc.</a> Discovering and developing innovative products that will transform the prevention and treatment of infectious diseases. Private 2008 View Profile
<a href="/venture-capital/all-companies/moderna">Moderna</a> Pioneering messenger RNA Therapeutics™, an entirely new in vivo drug modality. Private 2010 View Profile
<a href="/venture-capital/all-companies/ensemble-therapeutics-corporation">Ensemble Therapeutics Corporation</a> Discovering and developing novel small molecule therapies for cancer and other serious diseases. Private 2004 View Profile
<a href="/venture-capital/all-companies/quanterix-corporation">Quanterix Corporation</a> Developing ground-breaking tools in high definition diagnostics. Private 2007 View Profile
<a href="/venture-capital/all-companies/axcella-health">Axcella Health</a> Pioneering revolutionary new medicines with a focus on amino acid homeostasis. Private 2010 View Profile
<a href="/venture-capital/all-companies/midori">Midori</a> Revolutionizing health and sustainability through carbohydrate science, changing the landscape of food, medicine, renewable chemicals, and fuels. Private 2009 View Profile
<a href="/venture-capital/all-companies/tarveda-therapeutics-inc">Tarveda Therapeutics Inc.</a> Tarveda develops Pentarins™, which are novel miniaturized biologic drug conjugates uniquely designed to target, penetrate and treat solid tumors. Private 2012 View Profile